•  
  • iDrugSafety Pharmacovigilance Database

    Comply with the latest international and domestic standards, and cooperate with the pharmacovigilance system to improve the efficiency of pharmacovigilance work

 
  •  
  • Rapid reporting of safety data during clinical trials

    Provides solutions for drug safety in the clinical trial phase, and supports the electronic direct reporting CDE center

 
  •  
  • pharmacovigilance system construction

    Have international/domestic senior pharmacovigilance experts to help enterprises quickly establish a pharmacovigilance system

  •  
  • collect information

    Assist customers in developing and hosting call centers, WeChat, app, websites and other channels to collect drug adverse events

 
  •  
  • Case Processing

    Service personnel with many years of clinical and pharmacovigilance experience can conduct medical coding, medical examination and other case processing services.

 
  •  
  • Medical Writing

    Assist in writing FDAAR, DSUR, PSUR and other drug warning reports

  •  
  • Risk Management

    Artificial intelligence assists with signal detection and assists customers in developing risk management plans, risk minimization measures, etc.

 
  •  
  • Data Handling

    We can help pharmaceuticals transforming past paper data to electronic, structured and standardized data.

 
  •  
  • Medical Review

    Pharmacovigilance doctor with extensive clinical experience provides professional medical review services for pharmaceutical companies

济民可信

济民可信的存在价值,就是以济世之心,行惠民之举;诚信为品,造福天下。

江西济民可信集团有限公司创建于1999年,制药历史可追溯至上世纪五十年代,现有员工12000余名,总部位于中国南昌,在江西、北京、上海、江苏、浙江多地设有产业平台和研发机构。2017年,集团营业收入突破237亿元,跻身中国制药工业100强第6位、中国医药工业100强第10位。

秉承创新驱动的战略方针,公司专注于现代中药、化学药、生物制剂、保健品的研发、生产和销售,拥有7家制药基地、1座国际级博士后工作站、1个获CNAS认证的国家级实验室、5个省级工程技术中心,并在海外设立新药研发团队。当前,集团在心脑血管科、肾科、肿瘤科、抗感染及急救药物领域取得丰硕成果,核心产品“金水宝”、“醒脑静”、“康莱特”、“悉能”、“立幸”、“黄氏响声丸”、“九华痔疮栓”等在全国细分品类拥有较高市场份额。

Add to Favorites

Project Details

Date 18 March 2014 Categories Animation HTML5 Clean Design Author M.A Anderson
 
访问网站
 

Pharmacovigilance Partner

Pharmacovigilance News